Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-21

Clinical Trial Update: Reducing Discomforts in Critically Ill Patients: the IPREA3 Study [NA]

View source ↗

Summary

The IPREA3 study, aimed at reducing discomfort in critically ill patients, has completed according to the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Dr Pierre KALFON | Conditions: Critical Illness | NA | Status: COMPLETED